Splash celebration glitter
Pharma

$200M in 5 weeks: Behind RevMed's 'eye-popping' Rasonque debut

Generating $198 million in its first five weeks, Revolution Medicines’ RAS inhibitor daraxonrasib is living up to its much-hyped potential.
Fraiser Kansteiner Nov 5, 2026 11:11am
Asking More of Science How Daiichi Sankyo Is Challenging Assumptions About the Future of Cancer Care

Asking More of Science: How Daiichi Sankyo Is Challenging Assumptions About the Future of Cancer Care

Brought to you by Daiichi Sankyo, Inc.
JNJ

J&J’s Icotyde pill drives biologic-like efficacy again

Nov 9, 2026 10:02am
Leti CEA Tech APNEAband CES 2018 medical wearables sleep apnea sensorsmagcom Mathew Dirjish

Lilly eyes filing after Foundayo scores ph. 3 win in sleep apnea

Nov 9, 2026 9:30am
Tribeca campus Kings Cross London Kings Cross Knowledge Quarter

Moderna to move HQ across London to buzzy life-sci campus

Nov 9, 2026 8:30am
Image of Zepbound injectible with Eli Lilly oral weight loss drugs
Favicon Fierce Healthcare

Hims & Hers partners with Eli Lilly to sell Zepbound, Foundayo

Nov 6, 2026 4:30pm
More News

CMS locks in Medicare drug price negotiations for the long haul

Nov 6, 2026 4:24pm

Jeremy Pope joins ViiV in spreading 'PrEP Wisdom'

Nov 6, 2026 1:44pm

Moderna's COVID vax leads strong Q3 beat

Nov 6, 2026 12:00pm

The Oral GLP-1 Tracker: Foundayo's record, Wegovy pill's rebound

Nov 6, 2026 11:30am